Advertisement

Organisation › Details
T-Curx GmbH
T-CURX is a privately owned, German Biotech company based in Würzburg founded in 2017 with the vision of bringing next-generation CAR-T cell therapies manufactured with more cost-effective and highly scalable CAR-T cell technologies to more cancer patients in need of more effective cancer therapies. The proprietary CAR-T technologies of T-CURX were developed in the laboratory of co-founder Prof. Michael Hudecek at the University of Würzburg and are exclusively licensed to T-CURX. The highly efficient, scalable and cost-effective core technology is based on virus-free, Sleeping-beauty transposon gene transfer into patient’s T cells. Additional proprietary technologies that will be leveraged in T-CURX’ developing CAR-T cell product pipeline include (i) the proprietary Matchmaker technology for optimized potency and efficacy of T-CURX’ CAR-T cell products and (ii) a proprietary safety-switch that allows controlling the function of CAR-T cells after infusion into patients to improve the patient safety. *
![]() |
Start | 2017-03-06 established (s-off) |
Predecessor | University Hospital Würzburg (Universitätsklinikum Würzburg) | |
![]() |
Industry | cancer immunotherapy (immuno-oncology, I-O) |
Industry 2 | Sleeping Beauty transposon technology for gene editing | |
![]() |
Person | Grawunder, Ulf (T-Curx 202210– CEO + Co-Founder before NBE Therapeutics + 4-Antibody) |
Person 2 | Jung, Marion (T-Curx 202402– COO before ChromoTek Managing Director + Co-Founder + Earlybird Ventures) | |
![]() |
Region | Würzburg |
Country | Germany | |
Street | 15 Friedrich-Bergius-Ring Innovations- und Gründerzentrum Würzburg | |
City | 97076 Würzburg | |
Tel | +49-931-25099712 | |
Address record changed: 2024-02-11 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: T-Curx GmbH. (10/6/22). "Press Release: T-Curx GmbH, a German CAR-T Cell Biotech Spin-Off from University of Würzburg, Appoints Ulf Grawunder as CEO". Würzburg. | ||
Record changed: 2024-12-29 |
Advertisement

More documents for T-Curx GmbH
- [1] T-Curx GmbH. (2/9/24). "Press Release: T-Curx Extends Its Management Team with Marion Jung, PhD, as Its New Chief Operating Officer"....
- [2] T-Curx GmbH. (12/15/22). "Press Release: T-Curx GmbH Announces the Appointment of Thomas (Tom) Loeser as CFO and the Attendance at the JPM 41st Annual Healthcare Conference 2023 in San Francisco". Würzburg....
- [3] T-Curx GmbH. (10/6/22). "Press Release: T-Curx GmbH, a German CAR-T Cell Biotech Spin-Off from University of Würzburg, Appoints Ulf Grawunder as CEO". Würzburg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top